Skip to content
10-K

Annual Report

COCRYSTAL PHARMA, INC. COCP

0001493152-26-013838

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 24, 2026 13.79M sh
Shares Diluted FY 2025 · Dec 31, 2025 11.29M sh
Shares Diluted FY 2025 · Dec 31, 2024 10.17M sh
Capex FY 2025 · Dec 31, 2025 $12K
Capex FY 2025 · Dec 31, 2024 $8K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$8.19M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$16.49M
Cash And Equivalents FY 2025 · Dec 31, 2025 $7.03M
Cash And Equivalents FY 2025 · Dec 31, 2024 $9.86M
Stockholders Equity FY 2025 · Dec 31, 2025 $6.33M
Stockholders Equity FY 2025 · Dec 31, 2024 $9.52M
Stockholders Equity FY 2025 · Dec 31, 2023 $26.38M
Current Liabilities FY 2025 · Dec 31, 2025 $2.21M
Current Liabilities FY 2025 · Dec 31, 2024 $2.43M
Total Liabilities FY 2025 · Dec 31, 2025 $3.38M
Total Liabilities FY 2025 · Dec 31, 2024 $3.93M
Current Assets FY 2025 · Dec 31, 2025 $8.13M
Current Assets FY 2025 · Dec 31, 2024 $11.58M
Total Assets FY 2025 · Dec 31, 2025 $9.71M
Total Assets FY 2025 · Dec 31, 2024 $13.46M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.78
Eps Diluted FY 2025 · Dec 31, 2024 −$1.72
Eps Basic FY 2025 · Dec 31, 2025 −$0.78
Eps Basic FY 2025 · Dec 31, 2024 −$1.72
Sga Expense FY 2025 · Dec 31, 2025 $3.96M
Sga Expense FY 2025 · Dec 31, 2024 $5.34M
Rd Expense FY 2025 · Dec 31, 2025 $5.06M
Rd Expense FY 2025 · Dec 31, 2024 $12.54M
Net Income FY 2025 · Dec 31, 2025 −$8.83M
Net Income FY 2025 · Dec 31, 2024 −$17.5M
Operating Income FY 2025 · Dec 31, 2025 −$9.02M
Operating Income FY 2025 · Dec 31, 2024 −$17.88M